Poly (D,L-lactide)/nano-hydroxyapatite composite scaffolds for bone tissue engineering and biocompatibility evaluation.
Biodegradable polymer/bioceramic composite scaffolds can overcome the limitations of conventional ceramic bone substitutes such as brittleness and difficulty in shaping. However, conventional methods for fabricating polymer/bioceramic composite scaffolds often use organic solvents (e.g., the solvent casting and particulate leaching (SC/PL) method), which might be harmful to cells or tissues. In this study, Poly (D,L-lactide)/nano-hydroxyapatite (PDLLA/NHA) composites were prepared by in-situ polymerization, and highly porous scaffolds were fabricated using a novel method, supercritical CO2/salt-leaching method (SC CO2/SL). The materials and scaffolds were investigated by scanning electronic microscopy (SEM), transmission electronic microscopy (TEM) and gel permeation chromatography (GPC). GPC showed that the molecular weight of composites decreased with increase of NHA content. However, the water absorption and compressive strength increased dramatically. The SEM micrographs showed that the scaffolds with pore size about 250 microm were obtained by controlling parameters of SC CO2/SL. The biocompatibility of PDLLA/NHA porous scaffolds were evaluated in vitro and in vivo. The evaluation on the cytotoxicity were carried out by cell relative growth rate (RGR) method and cell direct contact method. The cytotoxicity of these scaffolds was in grade I according to ISO 10993-1. There was no toxicosis and death cases observed in acute systemic toxicity test. And histological observation of the tissue response (1 and 9 weeks after the implantation) showed that there are still some slight inflammation responses.
Ren
Jie
J
Institute of Nano and Bio-Polymeric Materials, School of Material Science and Engineering, Tongji University, Shanghai, 200092, P.R. China. renjie6598@163.com
Zhao
Peng
P
Ren
Tianbin
T
Gu
Shuying
S
Pan
Kefeng
K
D000818:Animals; D018786:Bone Substitutes / Q000009:adverse effects / Q000138:chemical synthesis*; D002470:Cell Survival; D002478:Cells, Cultured; D003188:Composite Resins / Q000009:adverse effects / Q000138:chemical synthesis / Q000737:chemistry; D017886:Durapatite / Q000009:adverse effects / Q000737:chemistry*; D005260:Female; D008297:Male; D008422:Materials Testing / Q000379:methods; D053758:Nanoparticles / Q000737:chemistry; D011091:Polyesters / Q000009:adverse effects / Q000737:chemistry*; D051381:Rats; D011919:Rats, Inbred Strains; D017207:Rats, Sprague-Dawley; D023822:Tissue Engineering / Q000379:methods; D054457:Tissue Scaffolds / Q000737:chemistry*
D018786:Bone Substitutes; D003188:Composite Resins; D011091:Polyesters; C499699:hydroxyapatite-polylactide; C033616:poly(lactide); D017886:Durapatite
Science. 2000 Sep 1;289(5484):1498-500
10991738
J Control Release. 2000 May 15;66(2-3):177-85
10742578
Clin Orthop Relat Res. 1991 Jul;(268):260-9
2060218
Science. 1993 May 14;260(5110):920-6
8493529
Tissue Eng. 1995 Spring;1(1):15-28
19877912
J Biomed Mater Res. 2001 Jun 5;55(3):401-8
11255194
Biomaterials. 1996 Jul;17 (14 ):1417-22
8830969
J Biomed Mater Res. 1997 Jul;36(1):17-28
9212385
J Biomed Mater Res. 2001 May;55(2):141-50
11255165
J Biomed Mater Res. 2000;53(1):1-7
10634946
Drug Discov Today. 2001 May 1;6(9):483-487
11344034
Biomaterials. 2004 Jun;25(13):2611-7
14751747
J Biomed Mater Res. 1998 Dec 5;42(3):396-402
9788501
Arch Surg. 1966 Nov;93(5):839-43
5921307
Biomaterials. 1999 May;20(9):859-77
10226712
J Control Release. 2000 Feb 14;64(1-3):91-102
10640648
Biotechnology (N Y). 1994 Jul;12(7):689-93
7764913
Biochem Biophys Res Commun. 2002 Mar 22;292(1):1-7
11890663
Biomaterials. 1998 Jul;19(14):1275-85
9720891
Oral Surg Oral Med Oral Pathol. 1971 Jan;31(1):134-9
5275497
J Biomed Mater Res. 2002 Aug;61(2):301-11
12007211
J Biomed Mater Res A. 2005 Sep 15;74(4):562-9
16025492